(19)
(11) EP 1 097 166 A2

(12)

(88) Date of publication A3:
20.04.2000

(43) Date of publication:
09.05.2001 Bulletin 2001/19

(21) Application number: 99944996.0

(22) Date of filing: 20.07.1999
(51) International Patent Classification (IPC)7C07K 14/47, C07K 14/475, C07K 16/00, C07K 16/28, C12N 5/10, C12N 15/12, C12N 15/63, G01N 33/53, G01N 33/567
(86) International application number:
PCT/US9916/471
(87) International publication number:
WO 0003/687 (27.01.2000 Gazette 2000/04)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 20.07.1998 US 93486 P
13.08.1998 US 96655 P

(71) Applicant: Elan Pharmaceuticals, Inc.
South San Francisco, CA 94080 (US)

(72) Inventors:
  • FORSAYETH, John, R.
    San Francisco, CA 94110 (US)
  • ZHAO, Byron, B.
    Palo Alto, CA 94303 (US)
  • CHAVEZ, Raymond, A.
    Alameda, CA 94501 (US)

(74) Representative: Denison, Christopher Marcus et al
Mewburn EllisYork House23 Kingsway
GB-London WC2B 6HP
GB-London WC2B 6HP (GB)

   


(54) POTASSIUM CHANNEL POLYPEPTIDE AND POLYNUCLEOTIDE COMPOSITIONS